Your browser doesn't support javascript.
loading
High prevalence of copy number variations in the Japanese participants with suspected MODY.
Tanaka, Satoshi; Akagawa, Hiroyuki; Azuma, Kenkou; Higuchi, Sayaka; Ujiie, Atsushi; Hashimoto, Koshi; Iwasaki, Naoko.
Affiliation
  • Tanaka S; Institute for Comprehensive Medical Sciences, Tokyo Women's Medical University, Tokyo, Japan.
  • Akagawa H; Diabetes and Metabolism, School of Medicine, Tokyo Women's Medical University, Tokyo, Japan.
  • Azuma K; Institute for Comprehensive Medical Sciences, Tokyo Women's Medical University, Tokyo, Japan.
  • Higuchi S; Department of Neurosurgery, Tokyo Women's Medical University Adachi Medical Center, Tokyo, Japan.
  • Ujiie A; Institute for Comprehensive Medical Sciences, Tokyo Women's Medical University, Tokyo, Japan.
  • Hashimoto K; Institute for Comprehensive Medical Sciences, Tokyo Women's Medical University, Tokyo, Japan.
  • Iwasaki N; Department of Diabetes, Endocrinology and Hematology, Dokkyo Medical University Saitama Medical Center, Saitama, Japan.
Clin Genet ; 106(3): 293-304, 2024 Sep.
Article in En | MEDLINE | ID: mdl-38733153
ABSTRACT
Maturity-Onset Diabetes of the Young (MODY) is a diabetes mellitus subtype caused by a single gene. The detection rate of the responsible gene is 27% in the United Kingdom, indicating that the causative gene remains unknown in the majority of clinically diagnosed MODY cases. To improve the detection rate, we applied comprehensive genetic testing using whole exome sequencing (WES) followed by Multiplex Ligation-dependent Probe Amplification (MLPA) and functional analyses. Twenty-one unrelated Japanese participants with MODY were enrolled in the study. To detect copy number variations (CNVs), WES was performed first, followed by MLPA analysis for participants who were negative on the basis of WES. Undetermined variants were analyzed according to their functional properties. WES identified 7 pathogenic and 3 novel likely pathogenic variants in the 21 participants. Functional analyses revealed that 1 in 3 variants was pathogenic. MLPA analysis applied to the remaining 13 undetermined samples identified 4 cases with pathogenic CNVs 3 in HNF4A and 1 in HNF1B. Pathogenic variants were identified in 12 participants (12/21, 57.1%) - relatively high rate reported to date. Notably, one-third of the participants had CNVs in HNF4A or HNF1B, indicating a limitation of WES-only screening.
Subject(s)
Key words

Full text: 1 Database: MEDLINE Main subject: Diabetes Mellitus, Type 2 / DNA Copy Number Variations / Exome Sequencing Limits: Adolescent / Adult / Female / Humans / Male / Middle aged Country/Region as subject: Asia Language: En Journal: Clin Genet Year: 2024 Type: Article Affiliation country: Japan

Full text: 1 Database: MEDLINE Main subject: Diabetes Mellitus, Type 2 / DNA Copy Number Variations / Exome Sequencing Limits: Adolescent / Adult / Female / Humans / Male / Middle aged Country/Region as subject: Asia Language: En Journal: Clin Genet Year: 2024 Type: Article Affiliation country: Japan